Table 2 |
||||
|
WOMAC scores at M3 in patients receiving Phytalgic® and those receiving placebo |
||||
|
Phytalgic® n = 41 |
Placebo n = 40 |
Difference Phytalgic® - Placebo |
P |
|
|
|
||||
|
Pain |
||||
|
Mean (± std) |
86.5 ± 94.3 |
235.3 ± 136.2 |
-148.8 ± 26.1 |
<0.001 |
|
[95% CI] |
[56.2; 116.9] |
[194.2; 276.5] |
[-97.7; -199.9] |
|
|
Stiffness |
||||
|
Mean (± std) |
41.4 ± 49.7 |
96.3 ± 71.0 |
-54.9 ± 13.8 |
<0.001 |
|
[95% CI] |
[25.6; 57.2] |
[74.5; 118.2] |
[-27.9; -81.9] |
|
|
Function* |
||||
|
Mean (± std) |
301.6 ± 315.6 |
746.5 ± 462.8 |
-444.8 ± 89.6 |
<0.001 |
|
[95% CI] |
[200.1; 403.1] |
[603.1; 890.0] |
[-269.1; -620.4] |
|
|
Total* |
||||
|
Mean (± std) |
430.1 ± 448.6 |
1085.4 ± 654.1 |
-655.2 ± 127.5 |
<0.001 |
|
[95% CI] |
[285.0; 575.1] |
[882.0; 1288.9] |
[-405.4; -905.1] |
|
|
|
||||
|
*four patients with missing scores at baseline, M1, M2 and M3 (two patients in each group). |
||||
|
Jacquet et al. Arthritis Research & Therapy 2009 11:R192 doi:10.1186/ar2891 |
||||
